Improved analytic modeling of the linear Rayleigh–Taylor instability with plasma transport
Physics of Plasmas · 01.07.2023 · 30 (7)
DOI: 10.1063/5.0155331 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physics of Plasmas, online erschienen am 13.07.2023. Verfasst von Brett D. Keenan und 1 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Renewable Energy Laboratory, National Nuclear Security Administration.
Abstract (Originalsprache)
The Rayleigh–Taylor (R–T) instability with transport effects has long been studied analytically in the neutral fluid regime. How this picture may differ in plasmas has been given less consideration, however. Leveraging previous numerical simulations with plasma viscosity and diffusion of R–T at a binary plasma interface, we show how plasma transport and kinetic effects alter the linear R–T dispersion relation. Our insight informs a much improved analytical dispersion relation, which better matches the simulation data than previously established models. Additionally, we demonstrate the importance of employing asymptotically correct viscosity coefficients in fluid codes for accurately capturing plasma R–T growth.
Förderung
- National Renewable Energy Laboratory
- National Nuclear Security Administration
Zitieren
APA
Keenan, B. D., & Sauppe, J. P. (2023). Improved analytic modeling of the linear Rayleigh–Taylor instability with plasma transport. Physics of Plasmas, 30(7). https://doi.org/10.1063/5.0155331
Vancouver
Keenan BD, Sauppe JP. Improved analytic modeling of the linear Rayleigh–Taylor instability with plasma transport. Physics of Plasmas. 2023;30(7). doi:10.1063/5.0155331
BibTeX
@article{Keenan2023,
author = {Keenan, Brett D. and Sauppe, Joshua P.},
title = {Improved analytic modeling of the linear Rayleigh–Taylor instability with plasma transport},
journal = {Physics of Plasmas},
year = {2023},
volume = {30},
number = {7},
doi = {10.1063/5.0155331}
}
EUVIMED